Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
- PMID: 35912744
- PMCID: PMC9535569
- DOI: 10.3233/JAD-220369
Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
Abstract
Background: The identification of risk factors for SARS-CoV-2 infection and mortality in patients with dementia is a key aspect to support clinical decisions and public health interventions.
Objective: To assess the incidence of SARS-CoV-2 infection and COVID-19 related death in a cohort of patients with dementia residing in the Lazio region and to investigate predicting factors for both infection and mortality.
Methods: This population-based study used information from administrative databases and the SARS-CoV-2 infection surveillance system. Patients with dementia (age ≥65) were enrolled as of December 31, 2019 and followed-up until February 28, 2021. Cumulative risk of infection and death within 60 days of infection onset, and age-standardized incidence (SIR) and mortality (SMR) ratios were calculated. Logistic regression models were applied to identify factors associated with infection and mortality.
Results: Among 37,729 dementia patients, 2,548 had a diagnosis of SARS-CoV-2 infection. The crude risk of infection was 6.7%. An increase in risk of infection was observed both in women (SIR 1.72; 95% CI 1.64-1.80) and men (SIR 1.43; 95% CI 1.33-1.54). Pneumonia, cerebrovascular and blood diseases, femur fracture, anxiety, antipsychotic and antithrombotic use were associated with an increased risk of infection. The crude risk of death was 31.0%, the SMRs 2.32 (95% CI 2.05-2.65) for men, and 2.82 (95% CI 2.55-3.11) for women. Factors associated with mortality included: male gender, age ≥85, symptoms at the diagnosis, antipsychotic and systemic antibiotics treatment.
Conclusion: These findings emphasize the need of close and tailored monitoring of dementia patients to reduce the impact of COVID-19 on this fragile population.
Keywords: Administrative databases; Alzheimer’s disease; COVID-19; SARS-CoV-2 infection; cohort study; dementia; prognostic factors.
Conflict of interest statement
Authors’ disclosures available online (
Figures
References
-
- Dorrucci M, Minelli G, Boros S, Manno V, Prati S, Battaglini M, Corsetti G, Andrianou X, Riccardo F, Fabiani M, Vescio MF, Spuri M, Urdiales AB, Manso M, Onder G, Pezzotti P, Bella Aon behalf of the Italian Integrated Surveillance COVID-19 group(2021) Excess mortality in Italy during the COVID-19 pandemic: Assessing the differences between the first and the second wave, year 2020. Front Public Health 9, 669209. - PMC - PubMed
-
- Canevelli M, Palmieri L, Raparelli V, Lo Noce C, Colaizzo E, Tiple D, Vaianella L, Vanacore N, Brusaferro S, Onder G, Italian NationalInstitute of Health COVID-19 Mortality Group (2020) Prevalenceand clinical correlates of dementiaamong COVID-19-related deaths in Italy. Alzheimers Dement(Amst) 12, e12114. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
